Molecular Biomarkers for the Evaluation of Colorectal Carcinoma: Guideline From the ASCP, CAP, AMP, and ASCO
- MeSH Terms
Intestinal Neoplasms (C06.405.249.411); Gastrointestinal Neoplasms (C06.405.249); Histological Techniques (E01.370.225.750); Histocytochemistry (E01.370.225.750.551); Histocytological Preparation Techniques (E01.370.225.750.600); Neoplasms (C04); Neoplasms by Histologic Type (C04.557); Carcinoma (C04.557.470.200); Neoplasms; Glandular and Epithelial (C04.557.470); Digestive System Neoplasms (C04.588.274); Colorectal Neoplasms (C04.588.274.476.411.307); Immunohistochemistry (E05.200.500.607.512); Individualized Medicine (E02.574); Molecular Diagnostic Techniques (E01.370.225.880); Diagnosis (E01)
- Guideline Contact
- Christina Ventura ([email protected])
- Keywords
- colorectal cancer, crc, biomarker testing, molecular marker testing
- Publication Date
- 06-Feb-17
- Expected Publication Date
- Update: Q4, 2025
- Publication Scope
- assessment
- Countries of Application
- United States
- Guideline Publication Status
- Under Review
- Languages
- English
- Authors
- CAP (US)
- Publication Year
- 2017